linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Company News  
Piramal Pharma Ltd.
 
BSE Code 543635
ISIN Demat INE0DK501011
Book Value 56.48
NSE Code PPLPHARMA
Dividend Yield % 0.07
Market Cap 266514.25
P/E 37.05
EPS 5.41
Face Value 10  
22-Aug-2025 Piramal Pharma Solutions, NewAmsterdam Pharma ope...
31-Jul-2025 Piramal Pharma informs about transcript of confer...
29-Jul-2025 Piramal Pharma reports consolidated net loss of R...
10-Jul-2025 Piramal Pharma informs about updates
02-Jun-2025 USFDA concludes GMP inspection at Piramal Pharma’...
02-Jun-2025 Piramal Pharma informs about disclosure
21-May-2025 Piramal Pharma informs about outcome of allotment...
15-May-2025 Piramal Pharma reports 51.57% rise in Q4 consolid...
12-May-2025 Piramal Pharma receives EIR from USFDA for Turbhe...
12-May-2025 Piramal Pharma gains on receiving EIR from USFDA ...
29-Apr-2025 Piramal Pharma informs about conference call
24-Apr-2025 Piramal Pharma’s arm inks pact with PPL Pharma
10-Apr-2025 Piramal Finance partners with ICICI Bank
03-Apr-2025 Piramal Pharma shines on commencing commercial pr...
02-Apr-2025 Piramal Pharma commences commercial production of...
Page 1 of 2
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.